In the considered cohort of ischemic stroke patients, the univariate Spearman test showed that there is a negative correlation between the expression of VEGFR2 on CD11b+ EVs (p = 0.044) and the MBI at admission (i.e., higher levels of VEGFR2 with lower MBI score, thus increased stroke severity and brain damage). This evidence concerns the gene ITGAM and ischemic stroke.